Apollo endosurgery announces preliminary 2021 revenue results; reflecting 50% growth over 2020

Fourth quarter 2021 revenue grew 25% over 2020 austin, tx / accesswire / january 10, 2022 / apollo endosurgery, inc. ("apollo" or the "company") (nasdaq:apen), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced preliminary unaudited revenue results for the fourth quarter and full year ended december 31, 2021. preliminary, unaudited 2021 revenue quarter ended december 31, 2021 year ended december 31, 2021 total revenue $16.1 million to $16.3 million $62.9 million to $63.1 million preliminary, unaudited full year 2021 revenue increased approximately 50% compared to 2020.
APEN Ratings Summary
APEN Quant Ranking